Research Paper Volume 13, Issue 10 pp 13954—13967
S100B gene polymorphisms are associated with the S100B level and Alzheimer’s disease risk by altering the miRNA binding capacity
Figure 2. Serum S100B levels among different groups. (A) Serum S100B levels between the AD patients and the controls. (B) Serum S100B levels among different genotypes in the AD patients (*P < 0.05).